Akso Health Group AHG
Last close
—
Market cap
—
52-week range
— - —
No price or market cap here: this company files no 10-K, so the only share count SEC publishes for it counts its ordinary shares in its home market, while its US listing is a depositary receipt standing for some number of them. That number is in no filing, so a price multiplied by that count is not this company's value and is not shown. The financial statements below are as filed.
Valuation FY2025 figures against the last close
P/S—
P/E—
P/FCF—
EV/EBITDA—
Dividend yield—
Diluted EPS0.01
Annual financial statements
Income statement
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $13.8M | $14.8M | $2.4M | $13.2M | $6.0M | $1.8M | $6.9M | $3.7M | $107.3M | $22.9M |
| Cost of revenue | $13.8M | $15.1M | $2.3M | $11.9M | $5.4M | $544.6K | $1.0M | $7.4M | $8.5M | $5.1M |
| Gross profit | -$11.3K | -$281.5K | $122.1K | $1.3M | $605.1K | $1.8M | $6.9M | -$3.7M | $107.3M | $22.9M |
| R&D | — | — | — | — | $421.2K | $441.4K | $117.9K | $0 | $2.8M | $1.6M |
| SG&A | $4.0M | $3.6M | $8.6M | $15.5M | $2.7M | $2.0M | $20.5M | $3.1M | $5.8M | $2.6M |
| Total operating expenses | $20.7M | $166.0M | $8.8M | $15.5M | $3.9M | $4.2M | $55.0M | $10.9M | $31.4M | $13.0M |
| Operating income | -$20.7M | -$166.3M | -$8.6M | -$14.3M | -$3.3M | -$4.2M | -$48.1M | -$7.2M | $75.9M | $9.9M |
| Interest expense | — | — | — | — | $804.1K | $2.2M | — | — | $590.1K | — |
| Pre-tax income | -$20.7M | -$166.3M | -$9.1M | -$13.1M | -$4.0M | -$4.3M | -$46.9M | -$6.8M | $76.5M | $10.1M |
| Income tax | $2.0M | $30.8M | $25.0K | $17.5K | $92.8K | $483.0K | $490.0K | $807.7K | $11.0M | $1.5M |
| Net income | -$18.7M | -$135.0M | -$9.5M | -$1.4M | -$16.9M | -$34.8M | -$71.2M | $5.5M | $65.5M | $8.6M |
| EPS, basic | 0.01 | 0.16 | 0.07 | -0.02 | -0.28 | -0.71 | -1.46 | 0.11 | 1.46 | 0.20 |
| EPS, diluted | 0.01 | 0.16 | 0.07 | -0.02 | -0.28 | -0.71 | -1.46 | 0.10 | 1.37 | 0.20 |
| Shares, diluted (wtd. avg.) | 2.17B | 855.3M | 141.5M | 68.6M | 59.6M | 48.8M | 48.8M | 52.9M | 47.7M | 42.3M |
Balance sheet
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $170.6K | $176.2M | $85.2M | $9.2M | $21.9M | $15.1M | $10.9M | $21.7M | $132.6M | $19.2M |
| Receivables | $1.3M | $954.2K | — | $7.7M | — | — | — | $140.6K | $0 | — |
| Inventory | $200.1K | $190.2K | $191.2K | $1.7M | $7.8M | — | — | — | — | — |
| Total current assets | $189.5M | $196.1M | $142.0M | $20.5M | $62.8M | $30.1M | $52.0M | $97.7M | $163.1M | — |
| Property, plant and equipment | $12.0K | $16.1K | — | — | $55.4K | $66.9K | $92.8K | $1.3M | $767.1K | $427.9K |
| Goodwill | — | $10.8M | $52.1M | — | — | — | — | — | — | — |
| Other intangibles | $58.3K | $7.9M | — | — | — | — | — | — | — | — |
| Total assets | $189.6M | $215.0M | $142.0M | $20.5M | $62.8M | $31.7M | $80.5M | $173.3M | $163.9M | $28.4M |
| Total current liabilities | $8.7M | $13.8M | $3.6M | $11.6M | $50.5M | $14.4M | $12.4M | $26.6M | $23.8M | — |
| Total liabilities | $8.7M | $15.8M | $3.6M | $11.6M | $50.5M | $14.4M | $32.4M | $46.8M | $23.8M | $4.9M |
| Retained earnings | -$217.6M | -$198.9M | -$63.9M | -$54.5M | -$53.1M | -$36.3M | -$1.4M | $69.8M | $77.2M | $11.8M |
| Total equity | $180.9M | $199.1M | $138.4M | $8.8M | $12.3M | $17.3M | $48.1M | $126.5M | $140.2M | $23.5M |
Cash flow
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$12.8M | $1.2M | $1.4M | -$3.3M | -$8.6M | $10.1M | -$58.3M | -$1.7M | $87.7M | $8.2M |
| Depreciation and amortisation | $6.7K | $1.6K | — | — | $18.4K | $15.2K | $120.5K | $17.2K | $174.4K | $92.2K |
| Stock-based compensation | — | — | — | — | $391.6K | $55.5K | $347.5K | $6.6M | $1.8M | — |
| Capital expenditure | $1.6K | $154.5K | — | — | $4.9K | — | $200.4K | $7.6K | $456.0K | $287.8K |
| Investing cash flow | -$163.5M | -$105.9M | -$54.7M | $18.5M | -$20.0M | -$662 | $12.8M | -$68.1M | -$27.6M | -$287.8K |
| Financing cash flow | $350.0K | $195.9M | $131.7M | -$27.5M | $34.8M | -$9.0M | -$1.6M | -$29.4K | $47.5M | $4.3M |
| Dividends paid | — | — | — | — | — | — | — | $19.5M | — | — |
| Buybacks | — | — | — | — | — | — | $2.7M | $1.3M | — | — |
Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001213900-26-080868.
Plot the figures US dollars
Income statement
Revenue
Cost of revenue
Gross profit
R&D
SG&A
Total operating expenses
Operating income
Interest expense
Pre-tax income
Income tax
Net income
EPS, basic
EPS, diluted
Shares, diluted (wtd. avg.)
- Revenue
- Gross profit
- Net income
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $22.9M | $107.3M | $3.7M | $6.9M | $1.8M | $6.0M | $13.2M | $2.4M | $14.8M | $13.8M |
| Gross profit | $22.9M | $107.3M | -$3.7M | $6.9M | $1.8M | $605.1K | $1.3M | $122.1K | -$281.5K | -$11.3K |
| Net income | $8.6M | $65.5M | $5.5M | -$71.2M | -$34.8M | -$16.9M | -$1.4M | -$9.5M | -$135.0M | -$18.7M |
Others in SIC 7389
| Ticker | Company | Market cap | P/E | Revenue growth |
|---|---|---|---|---|
| MA | Mastercard Inc | $550.02B | 37.7x | 16.4% |
| ACN | Accenture plc | $152.67B | 20.5x | 7.4% |
| UBER | Uber Technologies, Inc | $136.24B | 14.1x | 18.3% |
| MELI | MERCADOLIBRE INC | $91.77B | 45.9x | 34.3% |
| DASH | DoorDash, Inc. | $77.93B | 84.2x | 27.9% |
| EBAY | EBAY INC | $54.03B | 28.0x | 7.9% |
| PYPL | PayPal Holdings, Inc. | $50.30B | 10.5x | 4.3% |
| MSCI | MSCI Inc. | $44.76B | 39.2x | 9.7% |